Background:Since the introduction of direct-acting antivirals,thousands of chronic hepatitis C patients have been successfully treated.However,vulnerable populations have a higher prevalence of hepatitis C virus(HCV)i...Background:Since the introduction of direct-acting antivirals,thousands of chronic hepatitis C patients have been successfully treated.However,vulnerable populations have a higher prevalence of hepatitis C virus(HCV)infection and face barriers that impede their access to antivirals.We carried out an HCV microelimination program focused on vulnerable population groups in Malaga.Methods:People in drug addiction treatment centers and homeless shelters in Malaga who participated in the program between October 2020 and October 2021 were included.After providing participants with educational information on HCV,a dry drop test(DDT)was used to collect blood for subsequent screening for HCV infection.The participants who were diagnosed with HCV infection were scheduled for comprehensive healthcare assessments,including blood tests,ultrasonography,elastography,and the prescription of antivirals,all conducted in a single hospital visit.Sustained viral response(SVR)was analysed 12weeks after end of treatment.Results:Of the 417 persons invited to participate,271(65%)agreed to participate in the program.These participants were screened for HCV infection and 28 of them were diagnosed with HCV infection(10%).These hepatitis C-infected patients had a mean age of 53±9years;86%were males and 93%were or had been drug users.Among 23 patients with HCV infection,HCV genotype 1a predominated(74%).Medical exams showed that 19%(4/21)had advanced fibrosis(F3-4),and 5%(1/21)had portal hypertension.Finally,23 infected patients received treatment with glecaprevir/pibrentasvir or sofosbuvir/velpatasvir and SVR was confirmed in 22 patients(96%).Conclusions:Drug users and homeless people have a higher prevalence of HCV infection than the general population.The microelimination program with educational activity and screening tools achieved a high participation rate,easy healthcare access,and a high rate of SVR despite the SARS-CoV-2 pandemic.展开更多
基金supported by a grant from GILEAD for hepatitis C microelimination programs and the Instituto de Salud Carlos III[Río Hortega CM21/00074 to J.M.P.B.].
文摘Background:Since the introduction of direct-acting antivirals,thousands of chronic hepatitis C patients have been successfully treated.However,vulnerable populations have a higher prevalence of hepatitis C virus(HCV)infection and face barriers that impede their access to antivirals.We carried out an HCV microelimination program focused on vulnerable population groups in Malaga.Methods:People in drug addiction treatment centers and homeless shelters in Malaga who participated in the program between October 2020 and October 2021 were included.After providing participants with educational information on HCV,a dry drop test(DDT)was used to collect blood for subsequent screening for HCV infection.The participants who were diagnosed with HCV infection were scheduled for comprehensive healthcare assessments,including blood tests,ultrasonography,elastography,and the prescription of antivirals,all conducted in a single hospital visit.Sustained viral response(SVR)was analysed 12weeks after end of treatment.Results:Of the 417 persons invited to participate,271(65%)agreed to participate in the program.These participants were screened for HCV infection and 28 of them were diagnosed with HCV infection(10%).These hepatitis C-infected patients had a mean age of 53±9years;86%were males and 93%were or had been drug users.Among 23 patients with HCV infection,HCV genotype 1a predominated(74%).Medical exams showed that 19%(4/21)had advanced fibrosis(F3-4),and 5%(1/21)had portal hypertension.Finally,23 infected patients received treatment with glecaprevir/pibrentasvir or sofosbuvir/velpatasvir and SVR was confirmed in 22 patients(96%).Conclusions:Drug users and homeless people have a higher prevalence of HCV infection than the general population.The microelimination program with educational activity and screening tools achieved a high participation rate,easy healthcare access,and a high rate of SVR despite the SARS-CoV-2 pandemic.
